JP2001519787A5 - - Google Patents

Download PDF

Info

Publication number
JP2001519787A5
JP2001519787A5 JP1998541970A JP54197098A JP2001519787A5 JP 2001519787 A5 JP2001519787 A5 JP 2001519787A5 JP 1998541970 A JP1998541970 A JP 1998541970A JP 54197098 A JP54197098 A JP 54197098A JP 2001519787 A5 JP2001519787 A5 JP 2001519787A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP1998541970A
Other languages
English (en)
Japanese (ja)
Other versions
JP2001519787A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US1998/006445 external-priority patent/WO1998043555A1/en
Publication of JP2001519787A publication Critical patent/JP2001519787A/ja
Publication of JP2001519787A5 publication Critical patent/JP2001519787A5/ja
Ceased legal-status Critical Current

Links

JP54197098A 1997-04-03 1998-04-02 膀胱内ドラッグデリバリーシステム Ceased JP2001519787A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US83324797A 1997-04-03 1997-04-03
US08/833,247 1997-04-03
PCT/US1998/006445 WO1998043555A1 (en) 1997-04-03 1998-04-02 Intravesical drug delivery system

Publications (2)

Publication Number Publication Date
JP2001519787A JP2001519787A (ja) 2001-10-23
JP2001519787A5 true JP2001519787A5 (enExample) 2005-11-24

Family

ID=25263865

Family Applications (1)

Application Number Title Priority Date Filing Date
JP54197098A Ceased JP2001519787A (ja) 1997-04-03 1998-04-02 膀胱内ドラッグデリバリーシステム

Country Status (10)

Country Link
US (3) US6039967A (enExample)
EP (1) EP0971641A4 (enExample)
JP (1) JP2001519787A (enExample)
KR (1) KR20010006027A (enExample)
AU (1) AU6876498A (enExample)
CA (1) CA2285591A1 (enExample)
DE (1) DE19882286T1 (enExample)
GB (1) GB2338414B (enExample)
NO (1) NO994837L (enExample)
WO (1) WO1998043555A1 (enExample)

Families Citing this family (124)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6214331B1 (en) * 1995-06-06 2001-04-10 C. R. Bard, Inc. Process for the preparation of aqueous dispersions of particles of water-soluble polymers and the particles obtained
AR018321A1 (es) * 1998-03-26 2001-11-14 Alza Corp Una forma de dosificacion de liberacion prolongada que comprende oxibutinina y los usos de la oxibutinina y de la forma de dosificacion de liberacionprolongada.
US6623751B2 (en) * 1998-07-30 2003-09-23 L'oreal S.A. Cosmetic, pharmaceutical, or dermatological patch
US6293923B1 (en) 1999-03-15 2001-09-25 Innoventions, Inc. Intravesicular balloon
US6383471B1 (en) * 1999-04-06 2002-05-07 Lipocine, Inc. Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents
HUP0201626A3 (en) * 1999-06-04 2004-05-28 Alza Corp Mountain View Implantable gel compositions and method of manufacture
EP1949890A3 (en) * 1999-06-04 2011-05-18 ALZA Corporation Implantable gel compositions and method of manufacture
US6740039B1 (en) 1999-08-20 2004-05-25 Koninklijke Philips Electronics N.V. Methods and apparatus for displaying information relating to delivery and activation of a therapeutic agent using ultrasound energy
US6527718B1 (en) 1999-08-20 2003-03-04 Brian G Connor Ultrasound system for continuous imaging and delivery of an encapsulated agent
US7029694B2 (en) * 2000-04-26 2006-04-18 Watson Laboratories, Inc. Compositions and methods for transdermal oxybutynin therapy
US7179483B2 (en) * 2000-04-26 2007-02-20 Watson Pharmaceuticals, Inc. Compositions and methods for transdermal oxybutynin therapy
US20030124177A1 (en) * 2000-04-26 2003-07-03 Watson Pharmaceuticals, Inc. Compositions and methods for transdermal oxybutynin therapy
DE60143477D1 (de) 2000-04-26 2010-12-30 Watson Pharmaceuticals Inc Verminderung der nebenwirkungen bei der oxybutynin-therapie
US6398718B1 (en) 2000-06-15 2002-06-04 Innoventions, Inc. Intravesicular device
US6545046B2 (en) 2000-08-30 2003-04-08 Theramax Inc. Method for enhanced delivery of oxybutynin and compositions thereof
US6699665B1 (en) * 2000-11-08 2004-03-02 Surface Logix, Inc. Multiple array system for integrating bioarrays
US6558312B2 (en) 2001-03-13 2003-05-06 Clemson University Intraurethral device for incontinence
AU2002254167A1 (en) * 2001-03-13 2002-09-24 Clemson University Intraurethral device for treating or detecting various diseases or infections of the urinary system
KR100426636B1 (ko) * 2001-05-18 2004-04-08 한국과학기술연구원 주사 가능한 젤 상의 조성물 및 그의 제조방법
US6702744B2 (en) * 2001-06-20 2004-03-09 Advanced Cardiovascular Systems, Inc. Agents that stimulate therapeutic angiogenesis and techniques and devices that enable their delivery
US8110217B2 (en) * 2001-08-13 2012-02-07 University Of Pittsburgh Sphingomyelin liposomes for the treatment of hyperactive bladder disorders
US7063860B2 (en) * 2001-08-13 2006-06-20 University Of Pittsburgh Application of lipid vehicles and use for drug delivery
US6878693B2 (en) * 2001-09-28 2005-04-12 Solubest Ltd. Hydrophilic complexes of lipophilic materials and an apparatus and method for their production
US20050227911A1 (en) * 2001-09-28 2005-10-13 Solubest Ltd. Hydrophilic dispersions of nanoparticles of inclusion complexes of macromolecules
US20050233003A1 (en) * 2001-09-28 2005-10-20 Solubest Ltd. Hydrophilic dispersions of nanoparticles of inclusion complexes of salicylic acid
US6893431B2 (en) * 2001-10-15 2005-05-17 Scimed Life Systems, Inc. Medical device for delivering patches
US8563592B2 (en) 2001-11-01 2013-10-22 Spectrum Pharmaceuticals, Inc. Bladder cancer treatment and methods
AU2002350115A1 (en) * 2001-11-01 2003-05-12 Spectrum Pharmaceuticals, Inc. Medical compositions for intravesical treatment of bladder cancer
US7700851B2 (en) * 2001-11-13 2010-04-20 U.S. Smokeless Tobacco Company Tobacco nicotine demethylase genomic clone and uses thereof
US8608661B1 (en) 2001-11-30 2013-12-17 Advanced Cardiovascular Systems, Inc. Method for intravascular delivery of a treatment agent beyond a blood vessel wall
US8133501B2 (en) 2002-02-08 2012-03-13 Boston Scientific Scimed, Inc. Implantable or insertable medical devices for controlled drug delivery
US8685427B2 (en) * 2002-07-31 2014-04-01 Boston Scientific Scimed, Inc. Controlled drug delivery
US7361368B2 (en) 2002-06-28 2008-04-22 Advanced Cardiovascular Systems, Inc. Device and method for combining a treatment agent and a gel
US8920826B2 (en) * 2002-07-31 2014-12-30 Boston Scientific Scimed, Inc. Medical imaging reference devices
US7149874B2 (en) * 2002-08-16 2006-12-12 Micron Technology, Inc. Memory hub bypass circuit and method
EP1553899A4 (en) * 2002-10-22 2006-10-25 METHOD AND SYSTEM FOR INTRAVASCULAR DELIVERY OF THERAPEUTIC AGENTS
US7597903B2 (en) * 2002-12-02 2009-10-06 Shenkar College Of Engineering And Design Method and composition for producing catheters with antibacterial property
WO2004052440A1 (en) * 2002-12-11 2004-06-24 Coloplast A/S A urinary catheter device with a pharmaceutically active composition
JP2004246317A (ja) * 2002-12-20 2004-09-02 Hitachi Ltd 冷陰極型フラットパネルディスプレイ
EP1605863B1 (en) 2003-03-14 2016-09-07 Intersect ENT, Inc. Sinus delivery of sustained release therapeutics
US7641643B2 (en) 2003-04-15 2010-01-05 Abbott Cardiovascular Systems Inc. Methods and compositions to treat myocardial conditions
US8821473B2 (en) * 2003-04-15 2014-09-02 Abbott Cardiovascular Systems Inc. Methods and compositions to treat myocardial conditions
US8038991B1 (en) 2003-04-15 2011-10-18 Abbott Cardiovascular Systems Inc. High-viscosity hyaluronic acid compositions to treat myocardial conditions
CN101193623A (zh) 2003-05-15 2008-06-04 柏尔迈瑞克斯公司 可植入的网状弹性基质的制造和应用
US20040249364A1 (en) * 2003-06-03 2004-12-09 Ilya Kaploun Device and method for dispensing medication to tissue lining a body cavity
US20060177497A1 (en) * 2003-07-21 2006-08-10 Bio Dar Ltd. Gellan gum based oral controlled release dosage forms-a novel platform technology for gastric retention
NZ528648A (en) 2003-10-02 2005-08-26 Agres Ltd Altering animal waste composition
US20050175709A1 (en) * 2003-12-11 2005-08-11 Baty Ace M.Iii Therapeutic microparticles
US7763077B2 (en) 2003-12-24 2010-07-27 Biomerix Corporation Repair of spinal annular defects and annulo-nucleoplasty regeneration
WO2006013851A1 (ja) * 2004-08-03 2006-02-09 Nippon Shinyaku Co., Ltd. 体孔内用デバイス及び持続性製剤
US8361490B2 (en) * 2004-09-16 2013-01-29 Theracoat Ltd. Biocompatible drug delivery apparatus and methods
US7854944B2 (en) 2004-12-17 2010-12-21 Advanced Cardiovascular Systems, Inc. Tissue regeneration
EP1871383B1 (en) 2005-04-04 2017-11-15 Intersect ENT, Inc. Device and methods for treating paranasal sinus conditions
US9539410B2 (en) 2005-04-19 2017-01-10 Abbott Cardiovascular Systems Inc. Methods and compositions for treating post-cardial infarction damage
US8187621B2 (en) * 2005-04-19 2012-05-29 Advanced Cardiovascular Systems, Inc. Methods and compositions for treating post-myocardial infarction damage
US20080125745A1 (en) 2005-04-19 2008-05-29 Shubhayu Basu Methods and compositions for treating post-cardial infarction damage
US8303972B2 (en) * 2005-04-19 2012-11-06 Advanced Cardiovascular Systems, Inc. Hydrogel bioscaffoldings and biomedical device coatings
US8828433B2 (en) 2005-04-19 2014-09-09 Advanced Cardiovascular Systems, Inc. Hydrogel bioscaffoldings and biomedical device coatings
ATE540996T1 (de) 2005-06-06 2012-01-15 Univ British Columbia Polymerbasierter serumalbumin-ersatzstoff
EP1933810B1 (en) 2005-08-11 2012-10-10 Massachusetts Institute of Technology Intravesical drug delivery device and method
US7732190B2 (en) * 2006-07-31 2010-06-08 Advanced Cardiovascular Systems, Inc. Modified two-component gelation systems, methods of use and methods of manufacture
US9242005B1 (en) 2006-08-21 2016-01-26 Abbott Cardiovascular Systems Inc. Pro-healing agent formulation compositions, methods and treatments
WO2008035172A2 (en) * 2006-09-18 2008-03-27 Glenmark Pharmaceuticals Limited Pharmaceutical compositions containing desmopressin
US9005672B2 (en) * 2006-11-17 2015-04-14 Abbott Cardiovascular Systems Inc. Methods of modifying myocardial infarction expansion
US8741326B2 (en) * 2006-11-17 2014-06-03 Abbott Cardiovascular Systems Inc. Modified two-component gelation systems, methods of use and methods of manufacture
US8192760B2 (en) 2006-12-04 2012-06-05 Abbott Cardiovascular Systems Inc. Methods and compositions for treating tissue using silk proteins
US20080161639A1 (en) * 2006-12-28 2008-07-03 Olympus Medical Systems Corporation Capsule medical apparatus and body-cavity observation method
US8702591B2 (en) * 2007-01-12 2014-04-22 Olympus Medical Systems Corp. Capsule medical apparatus
DE102007003765A1 (de) * 2007-01-19 2008-07-24 Farco-Pharma Gmbh Pharmazeutische Zusammensetzung zur Behandlung von Inkontinenz
ES2481454T3 (es) * 2007-12-11 2014-07-30 Massachusetts Institute Of Technology Dispositivo implantable de administración de fármacos
CN101945621B (zh) 2007-12-18 2014-06-18 因特尔赛克特耳鼻喉公司 自扩展装置及用于其的方法
CA2732355A1 (en) 2008-08-01 2010-02-04 Intersect Ent, Inc. Methods and devices for crimping self-expanding devices
CN102176931B (zh) * 2008-08-09 2015-03-04 麻省理工学院 治疗男性泌尿生殖组织和外周组织的可植入药物递送设备和方法
US20100291182A1 (en) * 2009-01-21 2010-11-18 Arsenal Medical, Inc. Drug-Loaded Fibers
EP2424582B1 (en) 2009-04-28 2014-10-08 AMS Research Corporation Biologic treatment system and method
CN102458557B (zh) 2009-05-05 2018-11-27 德州大学系统董事会 挥发性麻醉剂的新型制剂及其用于减轻炎症的使用方法
WO2010132648A1 (en) 2009-05-15 2010-11-18 Intersect Ent, Inc. Expandable devices and methods therefor
CN101724163B (zh) * 2009-06-23 2011-09-07 河南科技大学 一种壳聚糖衍生物复合微球及其制备方法和应用
AU2010265866B2 (en) * 2009-06-26 2012-07-12 Taris Biomedical Llc Solid drug tablets for implantable drug delivery devices
DE102009035586A1 (de) 2009-07-31 2011-02-03 Fresenius Kabi Deutschland Gmbh Intravesikale Instillationslösungen zur Behandlung von Blasenkrebs
US10420862B2 (en) 2009-08-24 2019-09-24 Aresenal AAA, LLC. In-situ forming foams for treatment of aneurysms
US20110202016A1 (en) * 2009-08-24 2011-08-18 Arsenal Medical, Inc. Systems and methods relating to polymer foams
US9044580B2 (en) 2009-08-24 2015-06-02 Arsenal Medical, Inc. In-situ forming foams with outer layer
US9173817B2 (en) 2009-08-24 2015-11-03 Arsenal Medical, Inc. In situ forming hemostatic foam implants
US9017312B2 (en) 2009-09-10 2015-04-28 Taris Biomedical Llc Implantable device for controlled drug delivery
AU2015201123B2 (en) * 2009-12-17 2016-04-21 Taris Biomedical Llc Implantable device with intravesical tolerability and methods of treatment
AU2010339821B2 (en) 2009-12-17 2015-02-19 Taris Biomedical Llc Implantable device with intravesical tolerability and methods of treatment
DE212011100034U1 (de) 2010-01-20 2012-07-04 Theracoat Ltd. Material zur Behandlung von inneren Hohlräumen
CA2999629C (en) 2010-03-01 2020-12-15 The University Of British Columbia Derivatized hyperbranched polyglycerols
ES2729782T3 (es) 2010-08-05 2019-11-06 Taris Biomedical Llc Dispositivos implantables de administración de fármacos para sitios urogenitales
JP5945544B2 (ja) * 2010-10-06 2016-07-05 タリス バイオメディカル エルエルシー 時間選択的に生体吸収可能または崩壊可能な薬剤送達システムおよび方法
EP2663300B1 (en) 2011-01-10 2023-03-08 TARIS Biomedical LLC Lidocaine regimen for the use of sustained treatment of bladder pain and irritative voiding
US9194058B2 (en) 2011-01-31 2015-11-24 Arsenal Medical, Inc. Electrospinning process for manufacture of multi-layered structures
US9034240B2 (en) 2011-01-31 2015-05-19 Arsenal Medical, Inc. Electrospinning process for fiber manufacture
US8968626B2 (en) 2011-01-31 2015-03-03 Arsenal Medical, Inc. Electrospinning process for manufacture of multi-layered structures
KR20140048086A (ko) 2011-02-04 2014-04-23 타리스 바이오메디컬 인코포레이티드 저 용해성 약물의 제어 방출을 위한 이식가능한 디바이스
US8476221B2 (en) 2011-03-18 2013-07-02 Halimed Pharmaceuticals, Inc. Methods and compositions for the treatment of metabolic disorders
WO2013011504A1 (en) 2011-07-20 2013-01-24 Theracoat Ltd. Materials and method for treating internal body cavities
US8685418B2 (en) 2011-10-24 2014-04-01 Endo Pharmaceuticals Inc. Cyclohexylamines
US8993831B2 (en) 2011-11-01 2015-03-31 Arsenal Medical, Inc. Foam and delivery system for treatment of postpartum hemorrhage
IN2014DN09040A (enExample) 2012-05-19 2015-05-22 Taris Biomedical Llc
US10406332B2 (en) 2013-03-14 2019-09-10 Intersect Ent, Inc. Systems, devices, and method for treating a sinus condition
SG10201708522SA (en) 2013-03-15 2017-12-28 Taris Biomedical Llc Drug delivery devices with drug-permeable component and methods
CN113413537A (zh) 2013-08-19 2021-09-21 塔里斯生物医药公司 多单元药物递送装置和方法
AU2014365823B2 (en) 2013-12-16 2019-05-02 Abs Development 1, Inc. P2X3 and/or P2X2/3 compounds and methods
CN103861091B (zh) * 2014-03-20 2016-04-27 辽宁亿灵科创生物医药科技有限公司 治疗膀胱炎的药物组合物
CN114306899A (zh) 2014-06-26 2022-04-12 塔里斯生物医药公司 包含弹性聚合物-药物基质系统的膀胱内药物递送装置及方法
CZ308594B6 (cs) * 2014-09-29 2020-12-23 VÝZKUMNÝ ÚSTAV VETERINÁRNÍHO LÉKAŘSTVÍ, v.v.i. Mukoadhezivní nosiče částic, způsob přípravy a použití
CN107427668B (zh) 2015-01-22 2021-09-03 因特尔赛克特耳鼻喉公司 药物涂覆的气囊
KR102658706B1 (ko) 2015-04-23 2024-04-17 타리스 바이오메디컬 엘엘씨 약물-투과성 성분을 구비한 약물 전달 장치 및 방법
MX2019003710A (es) 2016-09-30 2019-06-24 Asana Biosciences Llc Compuestos y metodos de p2x3 y/o p2x2/3.
US20180256867A1 (en) * 2017-03-07 2018-09-13 Bruce H. Levin Nasal Delivery Device and Methods of Use
IT201700104446A1 (it) 2017-09-19 2019-03-19 Lo Li Pharma Srl Compositions, uses and methods for treatment of infertility and subfertility
BR112020012687A2 (pt) 2017-12-22 2020-11-24 Lo.Li. Pharma International S.R.L. uso de inositol
WO2020069376A1 (en) * 2018-09-27 2020-04-02 Watershed Medical, Inc. Device and method for treating infections
EP3924521A4 (en) 2019-02-15 2023-03-29 IncellDx, Inc. Assaying bladder-associated samples, identifying and treating bladder-associated neoplasia, and kits for use therein
IT201900003843A1 (it) 2019-03-15 2020-09-15 Lo Li Pharma Srl Trattamento di fibromi con vitamina D e un agente come l'epigallocatechina gallato (EGCG)
CN113939277B (zh) * 2019-04-30 2024-04-09 特瑞纲制药有限公司 用于药物输注到膀胱中和治疗膀胱疾病的制剂和方法
CA3140207C (en) 2019-06-13 2025-05-13 Hollister Incorporated REUSABLE URINARY CATHETER-TYPE PRODUCTS
AU2020304005B2 (en) 2019-06-25 2025-12-04 Hollister Incorporated Reusable urinary catheter products
US12403291B2 (en) 2019-08-30 2025-09-02 Intersect Ent, Inc. Submucosal bioresorbable drug eluting platform
US20210100950A1 (en) 2019-10-02 2021-04-08 Watershed Medical, Inc. Device and method for improving retention of a therapy in the bladder
US20250275988A1 (en) * 2022-04-19 2025-09-04 Watershed Medical, Inc. Formulation for treating urinary system disorders
IT202200013867A1 (it) 2022-06-30 2023-12-30 Lo Li Pharma Srl Composizione per il trattamento dell’ infezione da papilloma virus (hpv)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2961374A (en) * 1950-10-14 1960-11-22 Lieb Hans Injectable pharmaceutical preparation, and a method of making same
JPS51140582A (en) * 1975-05-30 1976-12-03 Nec Corp Semiconductor resistance element
US4774091A (en) * 1983-10-14 1988-09-27 Sumitomo Pharmaceuticals Company, Ltd. Long-term sustained-release preparation
FR2588189B1 (fr) * 1985-10-03 1988-12-02 Merck Sharp & Dohme Composition pharmaceutique de type a transition de phase liquide-gel
US4871542A (en) * 1987-04-30 1989-10-03 Ferring Service Center, N.V. Method and apparatus useful for delivering medicinal compositions into the bladder and urinary tract
FR2657018A1 (fr) * 1990-01-12 1991-07-19 Merck Sharp & Dohme Composition ophtalmique fluide a base de microparticules lipidiques contenant au moins un principe actif et son procede de preparation.
WO1991017745A1 (en) * 1990-05-23 1991-11-28 Southwest Research Institute Filament system for delivering a medicament and method
DE69329407T2 (de) * 1992-06-02 2001-05-03 Bard Inc C R Verfahren und Implantatvorrichtung für Langzeitwirkstoffabgabe

Similar Documents

Publication Publication Date Title
JP2000509635A5 (enExample)
JP2000509637A5 (enExample)
JP2000509912A5 (enExample)
JP2000509942A5 (enExample)
JP2000510751A5 (enExample)
JP2001525080A5 (enExample)
JP2002513422A5 (enExample)
JP2001519787A5 (enExample)
JP2000509587A5 (enExample)
JP2001508485A5 (enExample)
JP2000508866A5 (enExample)
JP2000510793A5 (enExample)
JP2000508841A5 (enExample)
JP2000508680A5 (enExample)
JP2000509804A5 (enExample)
JP2000509853A5 (enExample)
JP2002500550A5 (enExample)
JP2000509755A5 (enExample)
JP2000510969A5 (enExample)
JP2000510247A5 (enExample)
JP2000508836A5 (enExample)
JP2000509818A5 (enExample)
JP2000509520A5 (enExample)
JP2000508880A5 (enExample)
JP2001511839A5 (enExample)